相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships
Sahand Imani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis
Christina Koenig et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Survey of pharmacists' antibiotic dosing recommendations for sustained low-efficiency dialysis
Jian P. Mei et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2016)
Prolonged Intermittent Renal Replacement Therapy
Fahad Edrees et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2016)
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis A Meta-analysis of Individual Patient Data from Randomized Trials
Jason A. Roberts et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach
Katherine N. Gharibian et al.
CLINICAL NEPHROLOGY (2016)
Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy
Susan J. Lewis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Therapeutic drug monitoring of anti-infective agents in critically ill patients
Nynke G. L. Jager et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Piperacillin concentration in relation to therapeutic range in critically ill patients - a prospective observational study
Johannes Zander et al.
CRITICAL CARE (2016)
Extended Daily Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury: A Meta-analysis
Ling Zhang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Evaluating Outcomes of Alternative Dosing Strategies for Cefepime: A Qualitative Systematic Review
Sarah V. Burgess et al.
ANNALS OF PHARMACOTHERAPY (2015)
Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients
Evan Zasowski et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
Hui Yang et al.
PLOS ONE (2015)
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis
Eduardo Asin-Prieto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: A narrative and systematic review
Erlangga Yusuf et al.
JOURNAL OF CRITICAL CARE (2014)
Broad-spectrum β-lactams in obese non-critically ill patients
M. Hites et al.
NUTRITION & DIABETES (2014)
Medication Dosing in Critically Ill Patients With Acute Kidney Injury Treated With Renal Replacement Therapy
Bridget A. Scoville et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2013)
Underdosing of common antibiotics for obese patients in the ED
Jada L. Roe et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2012)
Low Cefepime Concentrations during High Blood and Dialysate Flow Continuous Venovenous Hemodialysis
F. Perry Wilson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations
Bernard Georges et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 Patients Treated with Concomitant CRRT
Seth R. Bauer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Cefepime Dosing in the Morbidly Obese Patient Population
Barrie S. Rich et al.
OBESITY SURGERY (2012)
Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration
Casey N. Gashti et al.
BLOOD PURIFICATION (2011)
Sustained low efficiency dialysis allows rational renal replacement therapy, but does it allow rational drug dosing?
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2011)
Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients
S. Christian Cheatham et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia
Sutep Jaruratanasirikul et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data
Sheryl A. Zelenitsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in three intensive care units from different countries
Mark R. Marshall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
Lucie Seyler et al.
CRITICAL CARE (2011)
High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
F. Lamoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation
Lois S. Lee et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Pharmacokinetics, Pharmacodynamics, and Monte Carlo Simulation Selecting the Best Antimicrobial Dose to Treat an Infection
John S. Bradley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Continuous-infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria
Brad Moriyama et al.
ANNALS OF PHARMACOTHERAPY (2009)
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit
Andrew F. Shorr
CRITICAL CARE MEDICINE (2009)
Accelerated venovenous hemofiltration: Early technical and clinical experience
Casey N. Gashti et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy
Julia Langgartner et al.
INTENSIVE CARE MEDICINE (2008)
An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis
Lena M. Maynor et al.
PHARMACOTHERAPY (2008)
Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms
Sunil V. Bhat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes
Sean M. Bagshaw et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Piperacillin-tazobactam for Pseudomonas aeruginosa infection:: Clinical implications of an extended-infusion dosing strategy
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2007)
In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies
Arantxazu Isla et al.
CHEMOTHERAPY (2007)
Cefepime neurotoxicity: Case report, pharmacokinetic considerations, and literature review
Sum Lam et al.
PHARMACOTHERAPY (2006)
Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
Christophe Mariat et al.
CRITICAL CARE (2006)
Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on beta-lactam antibiotics - Insights from the society of infectious diseases pharmacists
Thomas P. Lodise et al.
PHARMACOTHERAPY (2006)
Cefepime and continuous renal replacement therapy (CRRT):: In vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients
A Isla et al.
CLINICAL THERAPEUTICS (2005)
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous Venovenous Hemofiltration
A Arzuaga et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis
SC Mueller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure
D Chatellier et al.
INTENSIVE CARE MEDICINE (2002)
Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients
F Traunmuller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Severe neurotoxicity of cefepime in uremic patients
F Barbey et al.
ANNALS OF INTERNAL MEDICINE (2001)
Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients
RS Malone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit
VA Kumar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
GR Matzke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes
S Schmaldienst et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
